Loading clinical trials...

Ivacaftor (Kalydeco) and Insulin in Cystic Fibrosis (CF) | Clinical Trials | Clareo Health

COMPLETEDNCT02039986

Ivacaftor (Kalydeco) and Insulin in Cystic Fibrosis (CF)

This study is aimed at better understanding the impact of ivacaftor upon insulin and incretin secretion and glucose tolerance in patients with Cystic Fibrosis with a glycine (G551D) mutation. Investig...

Lead sponsor: Children's Hospital of Philadelphia•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITING

Impact of Sinus Surgery on Individuals With Cystic Fibrosis

NCT04469439 · Chronic Rhinosinusitis (Diagnosis), Cystic Fibrosis

RECRUITINGPhase 2

Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function

NCT04530383 · Cystic Fibrosis-related Diabetes, Cystic Fibrosis

RECRUITINGPhase 1

Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis

NCT06154447 · Cystic Fibrosis

RECRUITINGPhase 3

Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of Age

NCT05422222 · Cystic Fibrosis

RECRUITING

Physical Impairments in Children With Cystic Fibrosis

NCT06984679 · Cystic Fibrosis (CF), Cystic Fibrosis in Children

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 14, 2018Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment13

Start dateJan 2014

Last updatedDec 14, 2018

Condition

Cystic Fibrosis Related Diabetes Cystic Fibrosis

Locations shown

The Children's Hospital of Philadelphia

Philadelphia, Pennsylvania

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 14, 2018Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions